These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physical stability enhancement of theophylline via cocrystallization. Trask AV; Motherwell WD; Jones W Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188 [TBL] [Abstract][Full Text] [Related]
3. Theophylline-nicotinamide cocrystal formation in physical mixture during storage. Ervasti T; Aaltonen J; Ketolainen J Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which moisture generates cocrystals. Jayasankar A; Good DJ; Rodríguez-Hornedo N Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034 [TBL] [Abstract][Full Text] [Related]
5. The challenging case of the theophylline-benzamide cocrystal. Fischer F; Schmidt MU; Greiser S; Emmerling F Acta Crystallogr C Struct Chem; 2016 Mar; 72(Pt 3):217-24. PubMed ID: 26942431 [TBL] [Abstract][Full Text] [Related]
6. A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate. Evora AO; Castro RA; Maria TM; Silva MR; Ter Horst JH; Canotilho J; Eusébio ME Int J Pharm; 2014 May; 466(1-2):68-75. PubMed ID: 24607201 [TBL] [Abstract][Full Text] [Related]
7. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611 [TBL] [Abstract][Full Text] [Related]
8. Binary polymorphic cocrystals: an update on the available literature in the Cambridge Structural Database, including a new polymorph of the pharmaceutical 1:1 cocrystal theophylline-3,4-dihydroxybenzoic acid. Mnguni MJ; Michael JP; Lemmerer A Acta Crystallogr C Struct Chem; 2018 Jun; 74(Pt 6):715-720. PubMed ID: 29870007 [TBL] [Abstract][Full Text] [Related]
9. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations. Kumar S; Gupta A; Prasad R; Singh S Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053 [TBL] [Abstract][Full Text] [Related]
10. Cocrystals of acyclovir with promising physicochemical properties. Sarkar A; Rohani S J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552 [TBL] [Abstract][Full Text] [Related]
11. A new hydrate form of diflunisal precipitated from a microemulsion system. Sung HL; Fan YL; Yeh K; Chen YF; Chen LJ Colloids Surf B Biointerfaces; 2013 Sep; 109():68-73. PubMed ID: 23624616 [TBL] [Abstract][Full Text] [Related]
12. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy. Srivastava D; Fatima Z; Kaur CD Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461 [TBL] [Abstract][Full Text] [Related]
13. Influence of Secondary Interactions on the Structure, Sublimation Thermodynamics, and Solubility of Salicylate:4-Hydroxybenzamide Cocrystals. Combined Experimental and Theoretical Study. Manin AN; Voronin AP; Shishkina AV; Vener MV; Churakov AV; Perlovich GL J Phys Chem B; 2015 Aug; 119(33):10466-77. PubMed ID: 26258951 [TBL] [Abstract][Full Text] [Related]
14. Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals. Arenas-García JI; Herrera-Ruiz D; Morales-Rojas H; Höpfl H Eur J Pharm Sci; 2017 Jan; 96():299-308. PubMed ID: 27650458 [TBL] [Abstract][Full Text] [Related]
15. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form. Bartolomei M; Rodomonte A; Antoniella E; Minelli G; Bertocchi P J Pharm Biomed Anal; 2007 Nov; 45(3):443-9. PubMed ID: 17709225 [TBL] [Abstract][Full Text] [Related]
16. An investigation of the causes of cocrystal dissociation at high humidity. Eddleston MD; Thakuria R; Aldous BJ; Jones W J Pharm Sci; 2014 Sep; 103(9):2859-2864. PubMed ID: 24481664 [TBL] [Abstract][Full Text] [Related]
17. A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal. Li W; Pi J; Zhang Y; Ma X; Zhang B; Wang S; Qi D; Li N; Guo P; Liu Z Fitoterapia; 2018 Sep; 129():85-93. PubMed ID: 29936192 [TBL] [Abstract][Full Text] [Related]
18. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals. Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596 [TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of solutions. II. Flurbiprofen and diflunisal as models for studying solvation of drug substances. Perlovich GL; Kurkov SV; Bauer-Brandl A Eur J Pharm Sci; 2003 Aug; 19(5):423-32. PubMed ID: 12907293 [TBL] [Abstract][Full Text] [Related]
20. Novel furosemide cocrystals and selection of high solubility drug forms. Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]